Functional impact of androgen‐targeted therapy on patients with castration‐resistant prostate cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Functional impact of androgen‐targeted therapy on patients with castration‐resistant prostate cancer

Published:2022-08-24 Issue:6 Volume:3 Page:424-433
ISSN:2688-4526
Container-title:BJUI Compass
language:en
Short-container-title:BJUI Compass

Author:

Beer Tomasz M.¹,Shore Neal²,Morgans Alicia³,Winters‐Stone Kerri¹,Wefel Jeffrey S.⁴,George Daniel J.⁵

Affiliation:

1. Oregon Health and Science University Knight Cancer Institute Portland Oregon USA

2. Carolina Urologic Research Center Myrtle Beach South Carolina USA

3. Dana‐Farber Cancer Institute Boston Massachusetts USA

4. The University of Texas MD Anderson Cancer Center Houston Texas USA

5. Duke Cancer Institute Durham North Carolina USA

Publisher

Wiley

Subject

Religious studies,Cultural Studies

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/bco2.179

Reference78 articles.

1. Impact of Biochemical Recurrence in Prostate Cancer Among US Veterans

2. Second-Line Hormonal Therapy for Men With Chemotherapy-Naïve, Castration-Resistant Prostate Cancer: American Society of Clinical Oncology Provisional Clinical Opinion

3. Adverse effects of androgen-deprivation therapy in prostate cancer and their management

4. Reduced muscle strength and functional performance in men with prostate cancer undergoing androgen suppression: a comprehensive cross-sectional investigation

5. Management of Prostate Cancer in Elderly Patients: Recommendations of a Task Force of the International Society of Geriatric Oncology

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Treatment patterns for patients with BRCA1/2-positive metastatic castration-resistant prostate cancer;The Oncologist;2024-07-31

2. Clinical Outcomes After Stereotactic Body Radiation Therapy for Nonspinal Bone Metastases: A Systematic Review and Meta-analysis;International Journal of Radiation Oncology*Biology*Physics;2024-07

3. Metastatic Hormone-Sensitive Prostate Cancer and Combination Treatment Outcomes;JAMA Oncology;2024-06-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3